Church & Dwight Co Inc /de/ (CHD) · Oct 30, 2026 · Earnings

Church & Dwight earnings beat as organic growth powers 2026 raise

Beat — Adjusted EPS $0.92 vs ~$0.90 consensus

Church & Dwight’s Q3 earnings beat consensus, with 5.1% organic growth and a higher 2026 sales outlook validating its post-portfolio-reset strategy.

Church & Dwight is rebuilding growth after its 2025 portfolio exits, concentrating investment behind ARM & HAMMER, THERABREATH and international expansion. That strategy was already the company’s stated direction entering 2026, with management targeting faster core growth through those three initiatives.

The quarter cleared the external bar, but only narrowly on earnings. Published pre-release estimates were roughly $0.90 of adjusted EPS and $1.58 billion of revenue; Church & Dwight delivered $0.92 and $1.602 billion, respectively. The more important beat is operational: organic sales grew 5.1%, versus the company’s own 3% quarterly outlook, while volume contributed 4.6% and price/mix only 0.5%. 〔0〕

MetricQ3 2026Q3 2025Consensus / prior guide
Net sales (Financial Statements)$1,602.1M$1,585.6M~$1.58B
Adjusted EPS (Non-GAAP reconciliation)$0.92$0.81~$0.90
Organic sales growth (Organic Sales)5.1%—3.0% guide
Gross margin (Non-GAAP reconciliation)46.8%45.1%—
FY reported sales growth (Outlook)~0.5%—Flat to 1% prior guide
FY adjusted EPS growth (Outlook)7%—6% to 8% prior guide

The quality of growth is better than the headline sales number suggests. Reported revenue rose only 1.0% because the 2025 portfolio actions still create a comparison drag, but all three divisions posted organic growth: 4.4% domestic, 7.8% international and 5.0% specialty products. The strongest evidence that the core portfolio is working is the 4.6% volume increase, while the 170-basis-point gross-margin expansion shows productivity, mix and tariff refunds more than offset inflation and transportation costs. 〔1〕

The outlook moved up on sales, not because management abandoned investment. Full-year reported sales growth is now expected at approximately 0.5%, versus a prior range of flat to 1%, and organic growth is raised to approximately 5%, the top of the previous 4% to 5% range. Adjusted EPS growth is set at 7%, merely the midpoint of the old 6% to 8% range, as SG&A remains elevated from acquisitions and spending on growth, AI, e-commerce and international operations.

The quarter also gives Church & Dwight more capital-allocation flexibility, but that is secondary to the operating result. The board authorized a new $1 billion repurchase program, replacing the existing authorization, while the company ended September with $447 million of cash and $2.2 billion of total debt. Cash from operations is still expected at approximately $1.175 billion for the year, although nine-month operating cash flow was down 1.3% year over year.

Bottom line: This is a genuine, though not dramatic, upgrade to the business story: Church & Dwight is producing volume-led organic growth and margin expansion while working through the revenue hole from its portfolio exits. The sales outlook increase matters more than the EPS-range tightening, which is essentially a reaffirmation at the midpoint.

What to watch next

January investor meeting and first formal 2030 initiative update

Original filing on SEC EDGAR

More Church & Dwight Co Inc /de/ news

Church & Dwight earnings beat as organic growth powers 2026 raise | CHD Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.